All In Biotech

Drug Trial Radar · NCT02961764

Evaluation of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

A Pragmatic Trial Designed to Evaluate a New Critical Pathway for Treatment of Patients With Acute Bacterial Skin and Skin Structure Infections

Last checked: Nov 19, 2026Latest source record: Apr 10, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

313

Actual

Start

Nov 29, 2016

Primary completion

Mar 29, 2019

Study completion Mar 29, 2019

Sponsor

Lead sponsor
AllerganAbbVie (ABBV)
Sponsor type
Industry
First posted
Nov 11, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate a new critical pathway (use of guideline-based patient identification criteria and for those who meet these criteria, use of dalbavancin) for the treatment of ABSSSI compared to usual care.

Conditions

  • Acute Bacterial Skin and Skin Structure Infections

Interventions

  • Usual CareDrug

    Usual care as prescribed by the physician as standard of care in clinical practice for the treatment of ABSSSI.

  • DalbavancinDrug

    Dalbavancin administered as a single IV dose of 1500 mg over 30 minutes.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Hospital Admission Rate at Initial Episode of CareTime frame: 44 Days

Locations

11 sites in 1 country. Site status is shown where the registry gives one.

  • Maricopa Medical Center

    Phoenix, Arizona

  • Olive View-UCLA Medical Center

    Sylmar, California

  • Hartford Hospital

    Hartford, Connecticut

  • Tampa General Hospital

    Tampa, Florida

  • Rush University Medical Center

    Chicago, Illinois

  • Johns Hopkins Hospital

    Baltimore, Maryland

  • University of Massachusetts

    Worcester, Massachusetts

  • Henry Ford Hospital

    Detroit, Michigan

  • Wayne State University

    Detroit, Michigan

  • ProMedica Monroe Regional Hospital

    Monroe, Michigan

  • Truman Medical Centers

    Kansas City, Missouri

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.